DNA RNA and Cells

06 Feb 2007 SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-801i in Age-Related Macular Degeneration (AMD)
03 Feb 2007 Genta Completes Response to EMEA List of Outstanding Issues for Genasense® Marketing Authorization Application in Melanoma
02 Feb 2007 Alnylam Presents Pre-clinical Results from Hypercholesterolemia, Huntington's Disease and Neuropathic Pain Programs at Keystone Symposium on RNAi
30 Jan 2007 LCT to start clinical trial of type 1 diabetes treatment
30 Jan 2007 Advanced Viral Begins Phase II Dermatological Study
26 Jan 2007 Enzon Receives FDA Clearance of HIF-1 alpha Investigational New Drug Application
25 Jan 2007 Introgen Reports that INGN 241 in Combination with Avastin(R) Results in Complete Tumor Regression
23 Jan 2007 iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema
23 Jan 2007 Coley Pharmaceutical Group Updates Hepatitis C Drug Development Strategy
19 Jan 2007 Targeted Genetics Announces Publication of Inflammatory Arthritis Study in Molecular Therapy
18 Jan 2007 Aastrom Treats Patients in Adult Stem Cell Clinical Trial for Osteonecrosis
18 Jan 2007 Studies Show Geron's Stem Cell Therapeutic For Spinal Cord Injury Produces Nerve Growth Factors
18 Jan 2007 Archemix and Merck KGaA to Collaborate on Aptamer-Based Cancer Therapeutics
17 Jan 2007 Gentium Receives Orphan Drug Designation from FDA for Defibrotide to Prevent Hepatic Veno-occlusive Disease
16 Jan 2007 Osiris Therapeutics Receives European Orphan Drug Designation for PROCHYMAL
13 Jan 2007 ReNeuron provides a further update on the IND application for ReN001
12 Jan 2007 Ark Holds Positive End of Phase II Meeting with FDA on Trinam(R) Gene Therapy
12 Jan 2007 Genvec Receives Clearance From FDA For Eus Administration Of TNFerade
12 Jan 2007 Takara Bio Obtains Clinical Trial Approval of Gene Therapy Treatment for Chronic Granulomatosis
10 Jan 2007 Archemix Announces Collaboration with Pfizer to Discover Aptamer Therapeutics
10 Jan 2007 Alnylam and Inex Form Strategic Technology Alliance to Discover and Develop RNAi Therapeutics with Lipid-Based Delivery Formulations
10 Jan 2007 Mirus Bio Corporation Enters Into Agreement with Pfizer Inc to Evaluate RNAi Delivery Technology
09 Jan 2007 Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn’s Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
09 Jan 2007 ProNAi Announces Dna Interference (DNAI(R)) Drug Development Strategy For 2007
06 Jan 2007 Tengion Launches First Phase II Clinical Trial of Regenerated Human Organ

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up